Prognostic value of adjuvant therapy in T4 non‐small cell lung cancer: An inverse probability of treatment weighting analysis
Prognostic value of adjuvant therapy in T4 non‐small cell lung cancer: An inverse probability of treatment weighting analysis
复制标题
DOI：
10.1111/1759-7714.12960
复制
发表时间：
2019-01
期刊：
影响因子：
2.9
通讯作者：
Yayun Song;Sheng-Li Yang;Zhen Fu;Xue-han Liu;Siyu Yan;Zhi-hui Wang;T. Qin;Hong-wei Jiang;Yang Jin;P. Yin
中科院分区：
文献类型：
--
作者：
Yayun Song;Sheng-Li Yang;Zhen Fu;Xue-han Liu;Siyu Yan;Zhi-hui Wang;T. Qin;Hong-wei Jiang;Yang Jin;P. Yin
根据目前的临床指南，放化疗被认为是局部晚期非小细胞肺癌（NSCLC）的标准治疗。我们使用基于监测、流行病学和最终结果数据库的新的第八肿瘤淋巴结转移（TNM）分期系统分析了辅助化疗（ACT）对切除患者的预后影响。
According to the current clinical guidelines, chemoradiotherapy is considered the standard treatment for locally advanced non‐small cell lung cancer (NSCLC). We analyzed the prognostic effect of adjuvant chemotherapy (ACT) in resected patients using the new eighth tumor node metastasis (TNM) staging systems based on the Surveillance, Epidemiology and End Results database.